Raymond James & Associates’s Opko Health OPK Stock Holding History

Raymond James & Associates’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,000	Closed	-$3K	–	3688
2019 Q2	$3K	Buy	+14,000	New	+$30.5K	﹤0.01%	3619
2019 Q1	–	Sell	-36,000	Closed	-$1K	–	3689
2018 Q4	$1K	Hold	36,000	–	–	﹤0.01%	3528
2018 Q3	$1K	Hold	36,000	–	–	﹤0.01%	3630
2018 Q2	$11K	Hold	36,000	–	–	﹤0.01%	3523
2018 Q1	$4K	Buy	+36,000	New	+$145K	﹤0.01%	3435
2017 Q1	–	Sell	-65,000	Closed	-$7K	–	3362
2016 Q4	$7K	Hold	65,000	–	–	﹤0.01%	3203
2016 Q3	$55K	Hold	65,000	–	–	﹤0.01%	3074
2016 Q2	$62K	Buy	+65,000	New	+$660K	﹤0.01%	2862

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's OPK Position: Q3 2024 in Review

Raymond James & Associates increased its Opko Health (OPK) stake by 1% in Q3 2024, buying an estimated $594 and bringing the position to 38,665 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

Raymond James & Associates first reported a position in OPK in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.62M in Q3 2016. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

Raymond James & Associates held 38,665 shares of Opko Health worth $57.6K as of Q3 2024.
Raymond James & Associates bought 400 Opko Health shares in Q3 2024, an estimated $594.
Opko Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3837 holding.
Raymond James & Associates first reported a position in Opko Health in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's Opko Health position peaked at $4.62M in Q3 2016.
234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.